Taysha Gene Therapies Statistics
Total Valuation
TSHA has a market cap or net worth of $1.84 billion. The enterprise value is $1.59 billion.
Important Dates
The next estimated earnings date is Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSHA has 287.27 million shares outstanding. The number of shares has increased by 27.82% in one year.
| Current Share Class | 287.27M |
| Shares Outstanding | 287.27M |
| Shares Change (YoY) | +27.82% |
| Shares Change (QoQ) | +1.14% |
| Owned by Insiders (%) | 9.43% |
| Owned by Institutions (%) | 76.25% |
| Float | 198.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 188.12 |
| Forward PS | 662.68 |
| PB Ratio | 7.39 |
| P/TBV Ratio | 7.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 162.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.23, with a Debt / Equity ratio of 0.28.
| Current Ratio | 12.23 |
| Quick Ratio | 12.04 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,753.94 |
Financial Efficiency
Return on equity (ROE) is -68.45% and return on invested capital (ROIC) is -30.57%.
| Return on Equity (ROE) | -68.45% |
| Return on Assets (ROA) | -27.42% |
| Return on Invested Capital (ROIC) | -30.57% |
| Return on Capital Employed (ROCE) | -34.88% |
| Weighted Average Cost of Capital (WACC) | 9.81% |
| Revenue Per Employee | $98,717 |
| Profits Per Employee | -$1.10M |
| Employee Count | 99 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +251.65% in the last 52 weeks. The beta is 1.08, so TSHA's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +251.65% |
| 50-Day Moving Average | 4.82 |
| 200-Day Moving Average | 4.26 |
| Relative Strength Index (RSI) | 67.84 |
| Average Volume (20 Days) | 2,937,477 |
Short Selling Information
The latest short interest is 42.27 million, so 14.72% of the outstanding shares have been sold short.
| Short Interest | 42.27M |
| Short Previous Month | 46.39M |
| Short % of Shares Out | 14.72% |
| Short % of Float | 21.30% |
| Short Ratio (days to cover) | 13.54 |
Income Statement
In the last 12 months, TSHA had revenue of $9.77 million and -$109.00 million in losses. Loss per share was -$0.34.
| Revenue | 9.77M |
| Gross Profit | 9.77M |
| Operating Income | -110.50M |
| Pretax Income | -109.00M |
| Net Income | -109.00M |
| EBITDA | -109.35M |
| EBIT | -110.50M |
| Loss Per Share | -$0.34 |
Full Income StatementBalance Sheet
The company has $319.77 million in cash and $70.14 million in debt, with a net cash position of $249.62 million or $0.87 per share.
| Cash & Cash Equivalents | 319.77M |
| Total Debt | 70.14M |
| Net Cash | 249.62M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 246.94M |
| Book Value Per Share | 0.87 |
| Working Capital | 298.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$93.09 million and capital expenditures -$738,000, giving a free cash flow of -$93.83 million.
| Operating Cash Flow | -93.09M |
| Capital Expenditures | -738,000 |
| Depreciation & Amortization | 1.15M |
| Net Borrowing | 9.24M |
| Free Cash Flow | -93.83M |
| FCF Per Share | -$0.33 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,130.65% |
| Pretax Margin | -1,115.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSHA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.82% |
| Shareholder Yield | -27.82% |
| Earnings Yield | -5.93% |
| FCF Yield | -5.10% |
Analyst Forecast
The average price target for TSHA is $11.11, which is 73.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.11 |
| Price Target Difference | 73.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 94.25% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSHA has an Altman Z-Score of 1.72 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.72 |
| Piotroski F-Score | 2 |
